Ventana Discovery XT Ensures Reliable Immunohistochemistry Services at ProPath UK Limited
11 Feb 2014
In this video, Stuart Jones, Director of Molecular Pathology at Propath UK Limited, describes how the contract research organization is using the Ventana Discovery XT immunostaining platform for immuohistochemistry and in situ hybridization studies. Hear how methods are easily transferred from clients’ platforms to their own.
About the company
Ventana Medical Systems
Ventana Medical Systems, Inc. ("VMSI"), a member of the Roche Group, innovates and manufactures instruments and reagents that automate tissue processing and slide staining for cancer diagnostics. VENTANA products are used in clinical histology and drug development research laboratories worldwide. The company's intuitive, integrated staining, workflow management platforms, and digital pathology solutions optimize laboratory efficiencies to reduce errors, support diagnosis and inform treatment decisions for anatomic pathology professionals. Together with Roche, VMSI is driving Personalized Healthcare through accelerated drug discovery and the development of "companion diagnostics" to identify the patients most likely to respond favorably to specific therapies.